Neosens Diagnostics Sagl

AI-Platform Diagnostic Assistant for early health assessment

NEOSENS is an AI-based technology that provides rapid and accurate health assessment from a single drop of blood.

NEOSENS ensures newborns in LMICs receive the best possible start in life. Our technology brings together two key approaches for detecting neonatal sepsis. Traditional methods rely on observing clinical signs and risk factors, while more modern techniques measure the levels of infection indicators (known as biomarkers) in the blood.

NEOSENS merges these two approaches. We provide a point-of-care device which provides a rapid and reliable analysis, based
on the detection of sepsis biomarkers in the infant. This is then complemented with our predictive model software which calculated an accurate sepsis score.

This dual-analysis method enables doctors to make quick decisions.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
REGISTER

No milestones

No Jobs

Videos

NEOSENS

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Venture Kick (10'000) 2023

Website

Neosens Diagnostics Sagl

AI-Platform Diagnostic Assistant for early health assessment

Website:
neosens-dx.com/

Headquarter:
Agno

Foundation Date:
February 2025

Technology:

  • Medtech

Sectors:

  • Diagnostics
  • Infection
  • Machine Learning / AI
  • Inflammation
  • Medical devices
  • Medtech

Support received

  • Support venturekick